COO

Cooper CompaniesA

Nasdaq / Health Care Equipment & Services

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$81.00

Analysis reference price unavailable

Analysis 2026-09-10 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$69.00

Analysis reference price unavailable

Analysis 2026-09-10 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$54.00

Analysis reference price unavailable

Analysis 2026-09-10 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-09-10

AI commentary

Post-print coverage is negative around weak guidance and the CooperVision inventory overhang, despite a Q3 earnings beat, strong free cash flow, and buyback expansion. No reliable post-print analyst target changes, estimate revisions, options data, short-interest data, employee sentiment, or social coverage were supplied; confidence is therefore moderated. The prior bullish monitoring thesis has shifted to cautious event-driven monitoring.

RankAlpha Sentiment Codex - 2026-09-10

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-09-09eventQ3 FY2026 print and guidance resetMedium impact

Revenue rose 1% to $1.066 billion, non-GAAP EPS rose 4% to $1.15, and free cash flow rose 66% to $273 million. However, CooperVision was flat and management expects Q4 CooperVision organic growth of -2% to 0% and Q4 non-GAAP EPS of $1.05-$1.09. [#SEC-8K-2026-09-09]

2026-09-23catalystStrategic-review execution and capital allocationMedium impact

The Board retained CooperSurgical, expanded the repurchase authorization from $2 billion to $3 billion, and outlined commercial, efficiency, logistics, and innovation initiatives. CooperVision’s Vision Centre is scheduled to open September 23, 2026. [#SEC-8K-2026-09-09]

2026-10-31catalystCooperVision inventory digestionMedium impact

Management said proactive U.S. channel-inventory reduction weighed on Q3 results and will continue affecting Q4, creating near-term execution and estimate-risk pressure. [#SEC-8K-2026-09-09]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-09-10 • Updated nightlySource: Internal modelMethodology